158 related articles for article (PubMed ID: 38410602)
1. Understanding the systemic effects of intrapleural tPA and DNase by evaluating effects on coagulation.
Marston TW; Rajdev K; Samson KK; Hershberger DM
J Thorac Dis; 2024 Jan; 16(1):91-98. PubMed ID: 38410602
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
3. Rethinking the Doses of Tissue Plasminogen Activator and Deoxyribonuclease Administrated Concurrently for Intrapleural Therapy for Complicated Pleural Effusion and Empyema.
Innabi A; Surana A; Alzghoul B; Meena N
Cureus; 2018 Feb; 10(2):e2214. PubMed ID: 30755840
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
[TBL] [Abstract][Full Text] [Related]
5. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
6. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
Yokoyama Y; Kuno T; Takagi H; Burfeind W
Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
[TBL] [Abstract][Full Text] [Related]
7. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Altmann ES; Crossingham I; Wilson S; Davies HR
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
[TBL] [Abstract][Full Text] [Related]
8. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
[TBL] [Abstract][Full Text] [Related]
9. Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review.
Chan C; Sekowski V; Zheng B; Li P; Stollery D; Veenstra J; Gillson AM
J Bronchology Interv Pulmonol; 2023 Jul; 30(3):238-243. PubMed ID: 35698287
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Evaluation of Intrapleural Tissue Plasminogen Activator With or Without Dornase Alfa for the Treatment of Traumatic Retained Hemothorax: A 6-Year Experience.
Janowak CF; Becker BR; Philpott CD; Makley AT; Mueller EW; Droege CA; Droege ME
Ann Pharmacother; 2022 Feb; ():10600280221077383. PubMed ID: 35184602
[TBL] [Abstract][Full Text] [Related]
11. Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis.
Chong WH; Hu K; Saha BK; Chopra A
Pulm Pharmacol Ther; 2021 Dec; 71():102081. PubMed ID: 34571093
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
[TBL] [Abstract][Full Text] [Related]
13. Hemothorax With White-Out Lung After Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Therapy in a Patient With Complicated Parapneumonic Effusion.
Mainali A; Adhikari S; Chowdhury T; Gousy N; Bisural R; Devkota S; Kaphle Bastola AD
Cureus; 2022 Jun; 14(6):e26208. PubMed ID: 35891847
[TBL] [Abstract][Full Text] [Related]
14. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
[TBL] [Abstract][Full Text] [Related]
15. Mixing It Up: Coadministration of tPA/DNase in Complicated Parapneumonic Pleural Effusions and Empyema.
Bishwakarma R; Shah S; Frank L; Zhang W; Sharma G; Nishi SP
J Bronchology Interv Pulmonol; 2017 Jan; 24(1):40-47. PubMed ID: 27984384
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions.
Weinstein M; Restrepo R; Chait PG; Connolly B; Temple M; Macarthur C
Pediatrics; 2004 Mar; 113(3 Pt 1):e182-5. PubMed ID: 14993574
[TBL] [Abstract][Full Text] [Related]
17. Intrapleural therapy in management of complicated parapneumonic effusions and empyema.
Ahmed AH; Yacoub TE
Clin Pharmacol; 2010; 2():213-21. PubMed ID: 22291507
[TBL] [Abstract][Full Text] [Related]
18. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen Degradation by Neutrophil Elastase in Pleural Infection, Not High Plasminogen Activator Inhibitor-1 (PAI-1), is the Cause of Intrapleural Lytic Failure.
Barrett CD; Moore PK; Moore EE; Moore HB; Chandler JG; Siddiqui H; Maginot ER; Sauaia A; Pérez-Calatayud AA; Buesing K; Wang J; Davila-Chapa C; Hershberger D; Douglas I; Pieracci FM; Yaffe MB
Chest; 2024 May; ():. PubMed ID: 38710463
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study.
Jiang C; Xie M; Cervellione K; Thurm C
BMC Res Notes; 2020 Aug; 13(1):368. PubMed ID: 32746902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
